Exelixis, Inc.: Exelixis and Ipsen Announce Positive Results

Exelixis, Inc.: Exelixis and Ipsen Announce Positive Results from Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer

Exelixis, Inc.: Exelixis and Ipsen Announce Positive Results from Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Japan , United States , Cambridge , Cambridgeshire , United Kingdom , Shanghai , China , France , Saclay , France General , Paris , American , Neeraj Agarwal , Vickil Goodman , Susan Hubbard , Claire Mcconnaughey , Howard Mayer , Ipsen Euronext , Public Affairs , Exchange Commission , Nasdaq , European Union , Cancer Research At Huntsman Institute , Drug Administration , Exelixis Inc , World Cancer Research Fund International , Takeda Pharmaceutical Company Limited , Product Development Medical Affairs , Facebook , University Of Utah , Head Of Research , Presidential Endowed Chair , Cancer Research , Huntsman Cancer Institute , Executive Vice President , Chief Medical Officer , Hypertensive Crisis , Plantar Erythrodysesthesia , Impaired Wound Healing , Posterior Leukoencephalopathy Syndrome , Fetal Toxicity , Prescribing Information , Rare Disease , Sponsored Leveli American Depositary Receipt , Forward Looking Statements , Exelixi Quarterly Report , Annual Report , French Autorit , Des March , Universal Registration Document , Cancer Research Fund , Accessed August , Time From Metastasis , Overall Survival , Castration Resistant Prostate Cancer , Results From , Aktien Sie ,